Systemic effectors of alveolar bone mass and implications in dental therapy.
Department of Prosthodontics, University of North Carolina, Chapel Hill, North Carolina, USA.
L F
LF
Cooper
D016301:Alveolar Bone Loss / Q000209:etiology / Q000503:physiopathology*; D000818:Animals; D015519:Bone Density; D001861:Bone Regeneration; D002118:Calcium / Q000627:therapeutic use; D017742:Dental Care for Chronically Ill; D003758:Dental Implantation, Endosseous; D015921:Dental Implants; D017267:Dental Prosthesis Design; D006801:Humans; D008336:Mandibular Diseases / Q000209:etiology / Q000503:physiopathology*; D016348:Osseointegration; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D014807:Vitamin D / Q000627:therapeutic use
D015921:Dental Implants; D014807:Vitamin D; D002118:Calcium